In 1996 it was proposed that interleukin (IL)-1, an inflammatory cytokine whose levels are increased in the brains of patients with AD [9], may represent a driving force in the pathogenesis of AD [10,11]. The gene discussed is IL1B; the disease is Alzheimer disease.